0 CHECKOUT

PRODUCT FILTERS

REGION

CATEGORIES

  • 10
  • 9
  • 8
  • 6
  • 4
  • 4
  • 3
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1

PRICE

7
7
9
48

PUBLISHED

1
9
31
48

PRODUCT TYPE

42
5
1

Search for: "Lixte Biotechnology Holdings, Inc.-Therapeutic Competitors"

Lixte Biotechnology Holdings, Incorporation

A textual analysis of the financial results for Lixte Biotechnology Holdings, Incorporation compared to selected competitors. Also included are quantitative analyses of the company's financial statements,...

Published:  July 2016
Price: 

Brain Ischemia - Pipeline Review, H2 2015

Brain Ischemia - Pipeline Review, H2 2015 Summary The report ‘Brain Ischemia - Pipeline Review, H2 2015’, provides an overview of the Brain Ischemia’s therapeutic pipeline. This report provides comprehensive...

Published:  October 2015
Price:  From

Competitor Analysis: Enzyme Replacement Therapies

The Competitive Intelligence Report Enzyme Replacement & Enhancement Therapies (ERT) as of January 2013 provides a competitor analysis in the development pipeline of novel enzyme replacement therapies...

Published:  January 2013
Price:  From

Gaucher Disease - Pipeline Review, H1 2016

Gaucher Disease - Pipeline Review, H1 2016 Summary ‘Gaucher Disease - Pipeline Review, H1 2016’, provides an overview of the Gaucher Disease pipeline landscape. The report provides comprehensive...

Published:  June 2016
Price:  From

Lixte Biotechnology Holdings, Inc. (LIXT) - Strategic Analysis Review

Lixte Biotechnology Holdings, Inc. (Lixte) is a research based cancer therapeutics and diagnostics company engaged in development of improved treatments of human cancers. The company is currently developing...

Published:  September 2010
Price:  From

Neurofibromatoses Type II - Pipeline Review, H1 2016

Neurofibromatoses Type II - Pipeline Review, H1 2016 Summary ‘Neurofibromatoses Type II - Pipeline Review, H1 2016’, provides an overview of the Neurofibromatoses Type II pipeline landscape. The...

Published:  April 2016
Price:  From

Brain Ischemia - Pipeline Review, H1 2016

Brain Ischemia - Pipeline Review, H1 2016 Summary ‘Brain Ischemia - Pipeline Review, H1 2016’, provides an overview of the Brain Ischemia pipeline landscape. The report provides comprehensive information...

Published:  April 2016
Price:  From

Neurofibromatoses Type II - Pipeline Review, H2 2015

Neurofibromatoses Type II - Pipeline Review, H2 2015 Summary The report ‘Neurofibromatoses Type II - Pipeline Review, H2 2015’, provides an overview of the Neurofibromatoses Type II’s therapeutic...

Published:  December 2015
Price:  From

Neurofibromatoses Type II - Pipeline Review, H1 2015

Neurofibromatoses Type II - Pipeline Review, H1 2015 Summary The‘Neurofibromatoses Type II - Pipeline Review, H1 2015’, provides an overview of the Neurofibromatoses Type II’s therapeutic pipeline. This...

Published:  May 2015
Price:  From

Gaucher's Disease - Pipeline Review, H2 2015

Gaucher's Disease - Pipeline Review, H2 2015 Summary The report ‘Gaucher's Disease - Pipeline Review, H2 2015’, provides an overview of the Gaucher's Disease’s therapeutic pipeline. This report provides...

Published:  August 2015
Price:  From

Gaucher's Disease - Pipeline Review, H1 2015

Gaucher's Disease - Pipeline Review, H1 2015 Summary This, ‘Gaucher's Disease - Pipeline Review, H1 2015’, provides an overview of the Gaucher's Disease’s therapeutic pipeline. This report provides...

Published:  January 2015
Price:  From

Brain Ischemia - Pipeline Review, H1 2015

Brain Ischemia - Pipeline Review, H1 2015 Summary This, ‘Brain Ischemia - Pipeline Review, H1 2015’, provides an overview of the Brain Ischemia’s therapeutic pipeline. This report provides comprehensive...

Published:  April 2015
Price:  From

Neurofibromatoses - Pipeline Review, H1 2016

Neurofibromatoses - Pipeline Review, H1 2016 Summary ‘Neurofibromatoses - Pipeline Review, H1 2016’, provides an overview of the Neurofibromatoses pipeline landscape. The report provides comprehensive...

Published:  June 2016
Price:  From

Myocardial Ischemia - Pipeline Review, H1 2015

Myocardial Ischemia - Pipeline Review, H1 2015 Summary This, ‘Myocardial Ischemia - Pipeline Review, H1 2015’, provides an overview of the Myocardial Ischemia’s therapeutic pipeline. This report...

Published:  February 2015
Price:  From

Myocardial Ischemia - Pipeline Review, H1 2016

Myocardial Ischemia - Pipeline Review, H1 2016 Summary ‘Myocardial Ischemia - Pipeline Review, H1 2016’, provides an overview of the Myocardial Ischemia pipeline landscape. The report provides comprehensive...

Published:  March 2016
Price:  From

Septic Shock - Pipeline Review, H1 2016

Septic Shock - Pipeline Review, H1 2016 Summary ‘Septic Shock - Pipeline Review, H1 2016’, provides an overview of the Septic Shock pipeline landscape. The report provides comprehensive information...

Published:  April 2016
Price:  From

Medulloblastoma - Pipeline Review, H1 2014

Medulloblastoma - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Medulloblastoma - Pipeline Review, H1 2014’, provides an overview of the Medulloblastoma’s therapeutic pipeline. This...

Published:  February 2014
Price:  From

Septic Shock - Pipeline Review, H2 2015

Septic Shock - Pipeline Review, H2 2015 Summary The report ‘Septic Shock - Pipeline Review, H2 2015’, provides an overview of the Septic Shock’s therapeutic pipeline. This report provides comprehensive...

Published:  October 2015
Price:  From

Septic Shock - Pipeline Review, H1 2015

Septic Shock - Pipeline Review, H1 2015 Summary This, ‘Septic Shock - Pipeline Review, H1 2015’, provides an overview of the Septic Shock’s therapeutic pipeline. This report provides comprehensive...

Published:  April 2015
Price:  From

Ischemia - Pipeline Review, H2 2015

Ischemia - Pipeline Review, H2 2015 Summary The report ‘Ischemia - Pipeline Review, H2 2015’, provides an overview of the Ischemia’s therapeutic pipeline. This report provides comprehensive information...

Published:  December 2015
Price:  From
Loading Indicator

Our Clients

  • Glanbia Plc.
  • Unilever N.V.
  • Microsoft Corporation
  • Duke University
  • A.T. Kearney
  • PepsiCo Inc.
  • Boston Consulting Group